Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 17 - Number 9

From “An Enzyme Able to Destroy Penicillin” to Carbapenemases: 70 Years of Beta-lactamase Misbehaviour

, 17(9): 974 - 982

Jean-Marie Frère, Eric Sauvage and Frédéric Kerff

DOI: 10.2174/1389450116666151001112859

Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore

, 17(9): 983 - 1005

Donatella Tondi, Simon Cross, Alberto Venturelli, Maria P. Costi, Gabriele Cruciani and Francesca Spyrakis

DOI: 10.2174/1389450116666151001104448

Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art

, 17(9): 1072 - 1082

Magdalena Witkowska and Piotr Smolewski

DOI: 10.2174/1389450116666150907105306

MicroRNAs in Breast Cancer: One More Turn in Regulation

, 17(9): 1083 - 1100

Pilar E. Asensio, Eduardo T. Martin, Begona P. Merlo, Estefanía E. Armas and Ana L. Hernández

DOI: 10.2174/1389450116666150213114103


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog